Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients
K. E. McDonell, B. A. Preheim, A. Diedrich, J. A. S. Muldowney, A. C. Peltier, D. Robertson, I. Biaggioni, C. A. Shibao
This study evaluates the safety and efficacy of droxidopa in hospitalized patients with refractory neurogenic orthostatic hypotension, finding it safe and effective with high treatment persistence.
bioRxiv · Oct 8, 2018Pharmacology & Toxicology